GoodRx Holdings (GDRX) Other financing activities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Other financing activities data on file, last reported at $95000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 4650.0% year-over-year to $95000.0; the trailing twelve-month figure through Mar 2026 stood at $154000.0 (down 99.06% YoY), and the FY2025 full-year result was $61000.0, down 99.68% from the prior year.
• Other financing activities climbed to $95000.0 in Q1 2026, from -$799000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $18.2 million in Q4 2024 to a low of -$7.8 million in Q3 2022.
• A 5-year average of $2.5 million and a median of $783000.0 in 2023 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities tumbled 2827.12% in 2024 and soared 4650.0% in 2026, its largest moves.
• Tracing GDRX's Other financing activities over 5 years: stood at $9.2 million in 2022, then sank by 42.22% to $5.3 million in 2023, then soared by 243.71% to $18.2 million in 2024, then sank by 104.39% to -$799000.0 in 2025, then surged by 111.89% to $95000.0 in 2026.
• Business Quant data shows GDRX's Other financing activities at $95000.0 in Q1 2026, -$799000.0 in Q4 2025, and $858000.0 in Q2 2025.